FDA approves procysteine for human clinical trials. (Clintec)

DATELINE: Clintec

Clintec Nutrition Company, Deerfield, Illinois, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to begin Phase I, controlled human clinical trials with Procysteine, a precursor of the naturally occurring amino acid, L -cysteine.

Procysteine stimulates the synthesis of glutathione, which is essential for maintaining normal cellular function. Glutathione has been shown to inhibit replication of HIV in cell culture.

…